VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 27 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,877,858 | -23.3% | 338,167 | -46.2% | 0.01% | -26.7% |
| Q3 2022 | $12,886,000 | +46.7% | 628,275 | -17.2% | 0.02% | +50.0% |
| Q2 2022 | $8,783,000 | -39.3% | 759,128 | -3.1% | 0.01% | -28.6% |
| Q1 2022 | $14,479,000 | -4.2% | 783,095 | +2.4% | 0.01% | +7.7% |
| Q4 2021 | $15,116,000 | +27.5% | 764,613 | +6.1% | 0.01% | +18.2% |
| Q3 2021 | $11,853,000 | -10.0% | 720,530 | +0.0% | 0.01% | 0.0% |
| Q2 2021 | $13,176,000 | +318.3% | 720,373 | +282.1% | 0.01% | +266.7% |
| Q1 2021 | $3,150,000 | – | 188,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |